BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 30569855)

  • 1. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment-Enabled Nanotherapy.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.
    Chen S; Yang K; Tuguntaev RG; Mozhi A; Zhang J; Wang PC; Liang XJ
    Nanomedicine; 2016 Feb; 12(2):269-86. PubMed ID: 26707818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment.
    David A
    Adv Drug Deliv Rev; 2017 Sep; 119():120-142. PubMed ID: 28506743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.
    Curtis LT; Frieboes HB
    Adv Exp Med Biol; 2016; 936():165-190. PubMed ID: 27739048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical oncology: New targets for nanomedicine.
    Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
    Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting.
    Ahmad A; Khan F; Mishra RK; Khan R
    J Med Chem; 2019 Dec; 62(23):10475-10496. PubMed ID: 31339714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
    Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine as a potent strategy in melanoma tumor microenvironment.
    Pautu V; Leonetti D; Lepeltier E; Clere N; Passirani C
    Pharmacol Res; 2017 Dec; 126():31-53. PubMed ID: 28223185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
    Shi Y; van der Meel R; Chen X; Lammers T
    Theranostics; 2020; 10(17):7921-7924. PubMed ID: 32685029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsive and activable nanomedicines for remodeling the tumor microenvironment.
    Zhang Y; Han X; Nie G
    Nat Protoc; 2021 Jan; 16(1):405-430. PubMed ID: 33311713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.
    Lin G; Chen S; Mi P
    J Biomed Nanotechnol; 2018 Jul; 14(7):1189-1207. PubMed ID: 29944095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.